CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
104.34
-0.32 (-0.31%)
At close: Jun 26, 2026, 4:00 PM EDT
104.50
+0.16 (0.15%)
After-hours: Jun 26, 2026, 7:59 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for CVS Health stock have an average target of 104.56, with a low estimate of 92 and a high estimate of 115. The average target predicts an increase of 0.21% from the current stock price of 104.34.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CVS Health stock from 28 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 18 | 18 | 18 | 18 |
| Buy | 7 | 7 | 7 | 7 | 6 | 6 |
| Hold | 4 | 5 | 4 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 29 | 29 | 28 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $100 → $110 | Buy | Reiterates | $100 → $110 | +5.42% | Jun 23, 2026 |
| Bernstein | Bernstein | Buy Maintains $106 | Buy | Maintains | $106 | +1.59% | Jun 9, 2026 |
| UBS | UBS | Buy Maintains $100 → $115 | Buy | Maintains | $100 → $115 | +10.22% | Jun 8, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $110 → $115 | Buy | Maintains | $110 → $115 | +10.22% | Jun 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $103 | Buy | Maintains | $103 | -1.28% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
409.22B
from 399.83B
Increased by 2.35%
Revenue Next Year
426.48B
from 409.22B
Increased by 4.22%
EPS This Year
7.43
from 6.75
Increased by 10.13%
EPS Next Year
8.38
from 7.43
Increased by 12.77%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 425.8B | 446.0B | |
| Avg | 409.2B | 426.5B | |
| Low | 404.9B | 415.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.5% | 9.0% | |
| Avg | 2.3% | 4.2% | |
| Low | 1.3% | 1.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.65 | 8.95 | |
| Avg | 7.43 | 8.38 | |
| Low | 7.35 | 8.14 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.3% | 20.4% | |
| Avg | 10.1% | 12.8% | |
| Low | 8.9% | 9.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.